Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03765255 · ClinicalTrials.gov registry record · NA
Personal Responsibility Education Program Innovative Strategies: Digital Initiative for Youth
A NA study of Contraception and Sexually Transmitted Diseases, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,260
- Enrollment target
- 1
- Study location
NCT03765255: Completed NA study of Contraception and Sexually Transmitted Diseases, sponsored by University of California, San Francisco.
NCT03765255 is a NA study of Contraception and Sexually Transmitted Diseases that has completed, run by University of California, San Francisco. The registered enrollment target is 1,260 participants, above the 437-participant average among 72 other Contraception trials with a reported enrollment target (188% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03765255, a NA study of Contraception and Sexually Transmitted Diseases, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,260 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized control trial (RCT) will assess an innovative demonstration project to improve adolescent sexual and reproductive health among highly mobile and marginalized youth in Fresno County, California. The Digital Initiative for Youth intervention combines existing, in-person, group-based, comprehensive sexual health education with wraparound digital technologies. The technological component was designed by Youth+Tech+Health using a "youth-centered" design approach and the intervention is implemented by Fresno Economic Opportunities Commission (Fresno EOC). The University of California, San Francisco is the external evaluator. The RCT will assess health and behavioral outcomes at three time points (baseline, 4 months, 10 months).
Primary Outcome
Answered some or all of the time to: In the past 3 months, how often did you or a partner use birth control when you had vaginal sex OR In the past 3 months, how often did you use condoms when you had anal sex? Respondents complete computer-based survey. Survey developed by University of California, San Francisco (UCSF).
Conditions Studied
Interventions
- OTHER In the Know: sexual health education
Study Locations (1)
California
- Fresno Economic Opportunities Commission - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,260 participants |
| Start Date | 2017-10-17 |
| Est. Completion | 2021-03-30 |
| Phase | NA |
What the finished NCT03765255 record still lists
NCT03765255 is an interventional study that assigns participants to a tested intervention. Its 1,260 participants enrollment target places it among the larger protocols in the corpus, above the 437-participant average among 72 other Contraception trials with a reported enrollment target (188% higher).
The record links to 3 conditions, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which In the Know: sexual health education is the first listed.
NCT03765255 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03765255 about?
NCT03765255 is a clinical study titled "Personal Responsibility Education Program Innovative Strategies: Digital Initiative for Youth". This randomized control trial (RCT) will assess an innovative demonstration project to improve adolescent sexual and reproductive health among highly mobile and marginalized youth in Fresno County, California. The Digital Initiative for Youth intervention combines existing, in-person, group-based, c...
What is the current status of trial NCT03765255?
This trial is currently completed. It is a NA study. The enrollment target is 1,260 participants. The study started on 2017-10-17. Estimated completion is 2021-03-30.
What conditions does trial NCT03765255 study?
This clinical trial studies the following conditions: Contraception, Sexually Transmitted Diseases, Reproductive Health.
What interventions are being tested in trial NCT03765255?
The interventions under investigation include: In the Know: sexual health education (OTHER).
Who is sponsoring clinical trial NCT03765255?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03765255 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03765255's enrollment target sits among peer trials
1,260 7th of 72 higher than 66 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI